(R)-Praziquantel
- Generic Name
- (R)-Praziquantel
- Drug Type
- Small Molecule
- Chemical Formula
- C19H24N2O2
- CAS Number
- 57452-98-9
- Unique Ingredient Identifier
- WF15T5925V
- Background
(R)-Praziquantel is under investigation in clinical trial NCT02271984 (Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers).
L-PZQ ODT in Schistosoma Infected Children
Phase 3
Completed
- Conditions
- Schistosomiasis
- Interventions
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 288
- Registration Number
- NCT03845140
- Locations
- 🇰🇪
Kemri Kisumu, Kisumu, Kenya
🇨🇮Universitè de Cocody, Abidjan, Côte D'Ivoire
Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 48
- Registration Number
- NCT02315352
- Locations
- 🇹🇿
Ifakara Health Institute, Ikwiriri, Rufiji, Tanzania
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath